The ubiquitin-proteasome pathway has a welldefined beginning and end. Target proteins are initially recognized by upstream components and tagged with polyubiquitin chains. The 26S proteasome then degrades these polyubiquitinated proteins. Until recently, it was not known what, if any, steps occurred between the initial polyubiquitination of target proteins and their final degradation. Several new papers investigating the function of the Cdc48-Ufd1-Npl4 complex indicate that there is indeed a middle to the ubiquitin-proteasome pathway. The Cdc48-Ufd1-Npl4 complex functions in the recognition of several polyubiquitin-tagged proteins and facilitates their presentation to the 26S proteasome for processive degradation or even more specific processing. The elucidation of Cdc48, Ufd1 and Npl4 action not only provides long-sought functions for these specific proteins, but illuminates a poorly understood part of the ubiquitin-proteasome pathway.
Introduction
Geneticists hunt for mutants by casting very large nets, and it is often not obvious which genes will ultimately prove to be prize-winning catches, nor who has been fishing in the same waters. NPL4 and CDC48 were netted in separate expeditions to understand nuclear transport and the cell cycle. However, recent studies have shown these two distinct trophies to be intimately involved in a poorly understood part of the ubiquitin-proteasome pathway of degradation. In this pathway, multiple copies of the small protein (8 kDa) ubiquitin are covalently attached to a target protein, creating a polyubiquitin chain that serves as a signal for processive degradation, or even specific cleavage, by the 26S proteasome. Although the machinery of ubiquitination and the 26S proteasome are under intense scrutiny [1] [2] [3] , much less is known about what happens in vivo between the actual ubiquitination of a protein and its processing by the 26S proteasome.
From elegant in vitro experiments, it is clear that highly purified 26S proteasomes can alone recognize ubiquitinated proteins and degrade them [4] [5] [6] . But is this sufficient in vivo? In the cell, there are many possible impediments to 26S degradation of ubiquitinated substrates. These can include removal from membranes or compartments, dissociation from multiprotein complexes, or disassembly of a targeted substrates. This review discusses recent studies that suggest there can be a 'middle' to the ubiquitin-proteasome pathway and that the proteins coded by NPL4, UFD1 and CDC48 participate in this stage of the pathway by recognizing a variety of ubiquitinated proteins and presenting them to the 26S proteasome.
NPL4: Out of the Pore House, and into the ER NPL4 is an essential gene that was first identified in a selection for mutants defective in nuclear import [7] . At a restrictive temperature, npl4 mutants fail to import proteins bearing a nuclear localization sequence (NLS). They have gross defects in nuclear morphology and membrane herniations similar to those seen when some actual pore proteins, such as Nup116, are missing [7, 8] . Although these phenotypes are consistent with a role in nuclear transport, Npl4 has never been identified as a bona fide component of the nuclear pore despite exhaustive and highly effective efforts to identify all components of this complex in yeast [9] [10] [11] [12] . Recent data from an entirely different genetic screen clearly implicates Npl4 in the ubiquitin-proteasome degradation pathway.
In isolating hrd mutants that fail to degrade the enzyme HMG-CoA reductase, Bays et al. [13] found an allele of NPL4, hrd4-1, broadly deficient in ER-associated degradation, stabilizing both misfolded and normal proteins degraded by this pathway. The original npl4-1 and npl4-2 alleles isolated in the npl selection were also strongly deficient in ER-associated degradation at a temperature permissive for nuclear import and export, suggesting that a defect in ERassociated degradation was a primary phenotype in npl4/hrd4 mutants [13] , and not a secondary result of deficient nuclear transport. This was further supported by the observation that ER-associated degradation proceeds normally when nuclear import and export are blocked in a nup116∆ ∆ mutant -a null in a gene encoding an actual component of the pore with nuclear phenotypes strikingly similar to those of npl4 mutants [7, 8, 13] . As it had been previously noted that deficiencies in the ubiquitin-proteasome pathway can compromise nuclear import and export [14, 15] , the finding that npl4/hrd4 mutant cells suffer primarily from a block in ubiquitin-mediated degradation was not completely shocking.
The ER-associated degradation defect in npl4 mutants is quite general. The npl4 defect crosses several ubiquitin ligase boundaries in stabilizing both misfolded and regulated proteins. In order to determine where Npl4/Hrd4 acts in the ubiquitin-proteasome pathway, ubiquitination of HMG-CoA reductase (HMGR) was assayed in hrd4-1 mutant cells. In these strains, HMGR is fully ubiquitinated, consistent with the defect being downstream of ubiquitination [13] . Although this would be consistent with a defect in proteasome function, Npl4 has never been suggested to be a proteasome subunit. And general proteasome function is not deficient in npl4 mutant strains as shown using several cytosolic test substrates [13] .
The study of npl4 and hrd4 mutants makes two important points about Npl4 function. First, Npl4 shows an 'ER-centric' behavior in that it is broadly required for ER protein degradation, but does not seem to affect cytosolic protein degradation [13] . (Loss of Npl4 also induces an unfolded protein response [13] .) Second, Npl4 appears to act at a post-ubiquitination but preproteasome step in ER-associated degradation as the ER membrane protein HMGR is fully ubiquitinated but not degraded in npl4/hrd4 mutant cells. Npl4/Hrd4 therefore represents a previously uncharacterized step in ubiquitin-mediated protein degradation at the ER. The presence of this intermediate step is further indicated by study of the Cdc48/p97 protein and its binding partners.
Cdc48 Finally Finds a Function Free from Fusion
The AAA ATPase Cdc48 -also known as p97 or Valosin-containing protein, VCP -has been implicated in an even wider variety of cellular processes than Npl4, but like Npl4, recent data suggest that cdc48 phenotypes are caused by a defect in the ubiquitin-proteasome pathway, and specifically at a step after ubiquitination. It has been known for some time that CDC48 is required for the ubiquitin-mediated degradation of several short-lived proteins including N-end rule substrates and Iκ κBα α [16, 17] . In the study of Iκ κBα α degradation and a large-scale study to identify proteasome-interacting proteins, Cdc48 was found to associate physically with the 26S proteasome in an ATP-dependent manner [17, 18] . This raised the intriguing possibility that Cdc48 may act in the presentation of at least certain substrates to the 26S proteasome. Recent data support this idea and suggest that a Cdc48 complex acts broadly in the recognition and presentation of ubiquitinated proteins to the 26S proteasome.
Strikingly, Cdc48 can selectively recognize ubiquitinated proteins. In one study Dai and Li [19] find that several polyubiquitinated proteins copurify with VCP, the mammalian homologue of Cdc48, when tagged versions of VCP are affinity-purified from whole cell lysates. This copurification of polyubiquitinated proteins is inhibited by the addition of increasing amounts of tetra-ubiquitin chains. VCP preferentially binds tetra-ubiquitin chains in an ATP-dependent manner, with little affinity for mono-, di-, and tri-ubiquitin molecules in vitro [19] . This preference is especially interesting as tetra-ubiquitin is apparently a preferential unit in the recognition of polyubiquitin chains, and thus would be consistent with Cdc48 as a polyubiquitin chain binding protein [20, 21] .
The relevance of Cdc48's ability to recognize polyubiquitinated proteins is revealed by studies of virallyinduced ER protein degradation. In an attempt to escape detection by the immune system, the cytomegalovirus (CMV) gene product US11 orchestrates retrograde translocation of MHC class I heavy chain proteins from the ER to the cytosol for rapid degradation by the 26S proteasome [22, 23] . In a recent paper, Ye et al. [24] show that MHC retrotranslocation requires the mammalian Cdc48 homologue, p97. In semi-permeabilized cells expressing US11, addition of a dominant-negative version of p97 mutated in its conserved ATPase domain interferes with MHC retrotranslocation while an equal amount of wild-type p97 added to this in vitro system has no effect. This lack of wild-type effect may be due to the need for adding p97 complexes that include mammalian Npl4 and Ufd1 as well (see below).
If proteasome activity is inhibited in US11-expressing or CMV-infected cells, ubiquitinated heavy chain proteins can be found in the cytosol as degradation fails to follow retrotranslocation [23] . Importantly, Ye et al. [24] showed this was not the case when a dominant-negative p97 protein was present in the permeabilized assay. The p97 dominant-negative resulted in accumulation of ubiquitinated heavy chain proteins in a microsomal cell fraction rather than a soluble, cytosolic fraction as occurred when an equal amount of wild-type p97 was added under the same assay conditions [24] . Thus, blocking Cdc48/p97 activity had no apparent effect on the actual ubiquitination of heavy chain proteins, just as blocking Npl4 function in yeast also left ER-localized proteins fully ubiquitinated. In the case of US11-induced heavy chain degradation, this block occurs at the actual step of retrotranslocation of heavy chain proteins to the cytosol.
Unfortunately, no dominant-negative mutants of Npl4 are currently available to test whether blocking Npl4 activity in the Ye et al. experiments would also block retrotranslocation of heavy chain proteins, but there is very good reason to suspect that Npl4 acts with Cdc48 in US11-mediated retrotranslocation -with the first hints of guilt occurring by association. Cdc48 physically associates with an impressive array of proteins in the [24] suggest that the entire Cdc48-Ufd1-Npl4 complex does indeed act at the same step in ER-associated degradation (illustrated in Figure 1) . These experiments exploit the observation that the protein p47 competes with Ufd1-Npl4 for binding of Cdc48. When Ye et al. [24] added excess p47 to permeabilized cells to displace Ufd1-Npl4, retrotranslocation of heavy chains was blocked, consistent with a requirement for Npl4-Ufd1 binding to Cdc48 in this action. Unfortunately, p47 is not a benign Cdc48 binding partner, and p47 even decreases Cdc48 ATPase activity -an activity required for Cdc48 to function in heavy chain retrotranslocation.
An even more recent paper by Jarosch et al.
[26] studying the mutant, misfolded form of carboxypeptidase Y, CPY*, shows that loss of Ufd1 also blocks ERassociated degradation at a post-ubiquitination but pre-proteasome step. In order to be degraded by the cytosolic 26S proteasome, CPY* must be retrotranslocated from the ER lumen to the cytosol. Jarosch et al. [26] show that polyubiquitination by the ubiquitin-protein ligase Hrd1 and its associated ubiquitin-conjugating enzymes Ubc7 and Ubc1 is required for this retrotranslocation. While polyubiquitination of CPY* is blocked by hrd1∆ ∆ or ubc1∆ ∆/ / ubc7∆ ∆ mutations, CPY* is fully ubiquitinated in wild-type and ufd1-1 mutant cells.
Intriguingly, CPY* is also fully ubiquitinated in proteasome mutant strains, but in these strains ubiquitinated CPY* can be found in both cytosolic and ER membrane fractions showing that a fraction of CPY* is being retrotranslocated but not degraded when proteasome activity is compromised. This differs from wild-type and ufd1-1 strains where polyubiquitinated CPY* is found exclusively in ER membrane fractions. Therefore, ufd1-1 and proteasome mutant strains are blocked in CPY* degradation at a step following ubiquitination but only ufd1-1 strains are blocked in CPY* retrotranslocation, consistent with a role for the Cdc48-Ufd1-Npl4 complex in the retrotranslocation of substrates for ER-associated degradation. In a related paper, Rape et al. [33] study the role of Cdc48-Ufd1-Npl4 in Spt23 and Mga2 processing, but focus on events that occur after the proteasomal cleavage of Spt23 and Mga2. They show that when Spt23 is cleaved by the 26S proteasome, the active transcription factor domain (p90) can remain physically associated with the larger, unprocessed p120. Their studies implicate the Cdc48-Ufd1-Npl4 complex in the dissociation of processed p90 from the membrane anchored p120. When membrane fractions were isolated from yeast cells, both p120 and p90 were detected, as p90 remains associated with p120. Addition of Cdc48-expressing insect cell extracts caused the release of p90 from p120 and its appearance in the soluble fraction. Insect cell extract lacking Cdc48 did not cause this same mobilization of p90. Furthermore, addition of apyrase (to remove ATP) and NEM (to inhibit Cdc48 activity) blocked the ability of Cdc48-containing extract to mobilize p90 [33, 34] .
Cdc48-Ufd1-Npl4 Picks at the Remains of a Transcription Factor
When p120 and p90 membrane fractions were isolated from npl4-1 cells, Cdc48 was not able to cause the dissociation of p90 from p120 despite the lower levels of p90 produced due to the less efficient cleavage of p120 in npl4-1 strains. From these in vitro studies, it appears that Cdc48 is indeed acting as a chaperone in dismantling the protein-protein interaction between p90 and p120. What is striking about this Cdc48 chaperone action is that Cdc48 selectively binds the ubiquitinated protein in this complex. The term 'segregase' has been suggested for this action of Cdc48 [35] .
To characterize processing more fully, Rape et al.
[33] compared p90 generated naturally or from a coding region lacking the transmembrane region and only expressing the processed p90 fragment, referred to as Spt23p∆ ∆TM. They found that p90 derived from full-length Spt23 is ubiquitinated whereas the independently produced p90 is not. Thus, the ubiquitination of p90 comes about by its release from full-length Spt23. Importantly, only the ubiquitinated p90 physically associates with Cdc48 while nonubiquitinated Spt23p∆ ∆TM does not. Rape et al. [33] also showed that Cdc48 associates with the unstable and ubiquitinated N-end rule/ubiquitin fusion degradation (UFD) pathway substrate Ub-Pro-β β galactosidase while Cdc48 does not associate with the stable and nonubiquitinated Ub-Met-β β galactosidase. When added to other data in the paper, these results strongly suggest that Cdc48 can act as a chaperone with specificity for ubiquitinated proteins.
A The Hitchcock [30] and Rape [33] papers also emphasize two different functions for the Cdc48-Ufd1-Npl4 complex in the same OLE pathway (Figure 2) . Hitchcock et al. [30] show that the efficiency of Spt23 and Mga2 processing is reduced when components of the Cdc48-Ufd1-Npl4 complex are compromised. Because cells must produce OLE1 transcript in order to live, processing is not completely absent in the cdc48, npl4 and ufd1 mutants tested, but it is clearly less efficient. Rape et al. [33] show that the Cdc48-Ufd1-Npl4 complex is not just required for processing of Spt23, but that the complex is also required to separate the processed p90 protein from the p120 protein -a process that does not require the 26S proteasome. Here, in the same pathway, there are different uses for the ability of Cdc48-Ufd1-Npl4 to recognize selectively ubiquitinated proteins, and at least in one case to act as a molecular chaperone.
The study of the OLE pathway also provides yet another example of Cdc48-Ufd1-Npl4 action in ERassociated degradation. In an additional Jentsch lab paper, Braun et al. [35] show that the membrane bound Ole1 protein itself is unstable and undergoes ER-associated degradation. Degradation of Ole1 requires each member of the Cdc48-Ufd1-Npl4 complex: cdc48, ufd1 and npl4 mutants were each deficient in the degradation of Ole1.
Cdc48-Ufd1-Npl4 : Resolving Con-Fusion About Mutants
These recent data regarding the function of the Cdc48-Ufd1-Npl4 complex serve to make sense of diverse and seemingly disparate phenotypes, especially those originating from cdc48 and npl4 mutants. They also present compelling avenues of investigation. It is now a reasonable hypothesis that all npl4 and cdc48 phenotypes involve, somehow, loss of function in ubiquitin-or proteasome-mediated pathways. Therefore, processes involving the Cdc48-Ufd1-Npl4 complex, but with no known ubiquitin/proteasome connection, now elicit an investigation into whether ubiquitin/proteasome is involved. One example of such a process is membrane fusion. Cdc48 has been implicated for some time in homotypic ER membrane fusion [36] and Golgi vesicle fusion [37, 38] , but its role has not been extensively characterized. A recent report by Hetzer et al. [39] shows that Cdc48-Ufd1-Npl4 is required for membrane fusion, specifically to form a closed nuclear envelope at the end of mitosis in larger eukaryotes. Given this requirement for Cdc48-Ufd1-Npl4, it may be informative to seek directly roles for ubiquitin/proteasome in nuclear envelope formation specifically and in membrane fusion generally. New structural observations suggest an alternative to the 'ubiquitin only' interpretation for some functions of the Cdc48 complex. As mentioned earlier, p47 is a binding partner of Cdc48 and appears to act with Cdc48p in mediating certain membrane dynamics. The carboxy-terminal portion of p47 has a ubiquitinlike UBX domain. NMR studies now indicate that, despite the limited homology to ubiquitin (~14% identity), the tertiary structure of the p47 UBX domain is essentially superimposable with authentic ubiquitin [42] . This raises the intriguing possibility that p47 substitutes partially or completely for ubiquitin in some actions of the Cdc48 complex, allowing the same nanomechanical actions to be performed on molecules that are not ubiquitinated, but can interact with this clever 'p47-in-ubiquitin's clothing'.
Further Study of the Cdc48-Ufd1-Npl4 Complex Far more mechanistic information has been characterized for Cdc48 than for Npl4 or Ufd1. Data from the papers discussed here and elsewhere indicate that Cdc48 can act as an ATP-dependent chaperone, and Cdc48 can bind many different proteins -several of which are known to modulate directly its function [16, [43] [44] [45] [46] . Not much more is known about Ufd1 and Npl4 other than they are part of the long list of Cdc48-binding proteins and that they are both required for several ubiquitin-or proteasome-mediated processes.
To complicate the study of Cdc48-Ufd1-Npl4 further, the substrate range for Cdc48, Ufd1 and Npl4p implies that the three proteins do not always act together in ubiquitin-mediated protein degradation. While Cdc48 is required for the degradation of both N-end rule and UFD pathway substrates [16] , Ufd1 is only required for the degradation of UFD substrates and not N-end rule substrates [47] . Npl4 is required for neither group of substrates [13] . (One experiment in Rape et al. [33] does show stabilization of Ub-Pro-β β galactosidase in a npl4-1 strain but the chase was performed after incubation at the restrictive temperature. The experiments in Bays et al. [13] testing cytosolic N-end rule, UFD and Deg1 substrates were all performed at the permissive temperature where npl4/hrd4 mutants show a strong block in ER-associated degradation.) Discovering exactly how Ufd1 and Npl4 affect Cdc48 function will undoubtedly become a major focus in future studies of Cdc48-Ufd1-Npl4 function.
Cdc48-Ufd1-Npl4 has broader implications for the nature of the ubiquitin-proteasome system. The phenotypes resulting from loss of this complex strongly suggest that there can be intermediate steps following ubiquitination that must take place in order for a ubiquitinated protein to be recognized and processed by the 26S proteasome. Now studies will focus on how general the requirement for an intermediate step is, what events are actually occurring in such intermediate steps, and how many different proteins can act as an intermediary between ubiquitinated proteins and the 26S proteasome. All of these studies will produce exciting and illuminating insights into the ubiquitin-proteasome pathway.
